TopFunds

Viatris

NASDAQ: VTRS

Stock price

17.44 USD

(+0%) TODAY

PharmaceuticalsDrug Manufacturers - Specialty & Generic
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.7
0.9
1.3
0.7
-
(1.1)
(1)
1.7
-
(0.5)
(3)
-
02Free cash flow per share
3.3
3.2
3.3
4
2.7
0.9
2.1
2.1
1.9
1.7
1.7
(6.7)%
03Dividends per share
-
-
-
-
-
-
0.3
0.5
0.5
0.5
0.5
9.8%
04Dividends payout, %
-
-
-
-
-
-
(31.4)%
28%
10.5%
(90.6)%
(16)%
(15.6)%
PROFIT AND LOSS STATEMENT
05Revenue
9,429
11,077
11,908
11,434
11,501
11,946
17,886
16,263
15,427
14,739
14,300
4.3%
06% Change
-
-
-
-
-
-
-
-
-
-
-
4.3%
07Cost of revenue
(5,213)
(6,380)
(7,125)
(7,432)
(7,603)
(8,149)
(12,311)
(9,766)
(8,988)
(9,116)
(9,286)
5.9%
08Gross profit
4,216
4,697
4,783
4,002
3,898
3,797
5,576
6,497
6,439
5,624
5,014
1.8%
09% Margin
44.7%
42.4%
40.2%
35%
33.9%
31.8%
31.2%
40%
41.7%
38.2%
35.1%
37.6% A
10Operating expenses
(2,755)
(3,998)
(3,346)
(3,096)
(3,182)
(4,008)
(5,610)
(4,882)
(5,672)
(5,614)
(7,677)
10.8%
11% of Revenue
(29.2)%
(36.1)%
(28.1)%
(27.1)%
(27.7)%
(33.6)%
(31.4)%
(30)%
(36.8)%
(38.1)%
(53.7)%
(33.8)% A
12Operating Income
1,461
699.2
1,437
905.6
715.5
(210.8)
(34)
1,615
766.2
10.1
(2,663)
-
13Income tax expense
(67.7)
(358.3)
(207)
(54.1)
(137.6)
(51.3)
(604.7)
(734.6)
(148.2)
(11)
(150.1)
-
14Net Income
847.6
480
696
352.5
16.8
(669.9)
(1,269)
2,079
54.7
(634.2)
(3,515)
-
15% Margin
9%
4.3%
5.8%
3.1%
0.2%
(5.6)%
(7.1)%
12.8%
0.4%
(4.3)%
(24.6)%
(0.6)% A
16Shares Outstanding
497.4
520.5
536.7
516.5
516.5
601.2
1,209
1,217
1,207
1,193
1,171
8.9%
17EPS Basic
1.8
0.9
1.3
0.7
-
(1.1)
(1)
1.7
-
(0.5)
(3)
-
18EPS Diluted
1.7
0.9
1.3
0.7
-
(1.1)
(1)
1.7
-
(0.5)
(3)
-
19EBITDA
2,287
2,100
3,243
2,951
2,691
1,993
4,478
6,433
3,517
2,820
(395.4)
-
% Margin
24.3%
19%
27.2%
25.8%
23.4%
16.7%
25%
39.6%
22.8%
19.1%
(2.8)%
21.8% A
20Net Interest Income (expense)
(336.4)
(442.5)
(534.6)
(542.3)
(517.3)
(497.8)
(636.2)
(592.4)
(573.1)
(550)
(471.3)
3.4%
21Net Debt / EBITDA
2.7
6.9
4.4
4.6
4.6
12.7
5.1
2.8
4.9
4.8
(33.8)
1.8 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,236
998.8
292.1
388.1
475.6
844.4
701.2
1,260
991.9
734.8
1,348
0.9%
23Short-term investments
54
83.8
110.6
57.5
109.1
203.5
233.8
212.6
192.5
355.1
106.4
7%
24Accounts receivable
2,434
3,015
3,173
2,417
3,059
4,844
4,266
4,143
4,041
3,522
3,347
3.2%
25Other current assets
601.3
912.3
1,087
921.8
442.9
1,504
1,724
1,501
4,281
1,055
420.2
(3.5)%
26Inventory
1,951
2,456
2,543
2,580
2,671
5,472
3,978
3,520
3,470
3,854
3,999
7.4%
27Total Current Assets
6,473
7,523
7,213
6,368
6,757
12,868
10,903
10,635
12,976
9,521
9,221
3.6%
Non-Current Assets
28Net property, plant & equipment
1,984
2,322
2,339
2,170
2,404
3,784
3,479
3,284
3,005
2,919
2,885
3.8%
29Long-term investments
475.5
396.4
226
138.7
92.2
47.9
81.4
1,091
1,142
1,350
815
5.5%
30Other non-current assets
13,336
24,485
26,028
24,058
22,002
44,854
40,379
35,012
30,562
27,711
24,272
6.2%
31Total Non-Current Assets
15,795
27,204
28,593
26,367
24,498
48,686
43,940
39,387
34,709
31,980
27,972
5.9%
Total Assets
22,268
34,726
35,806
32,735
31,256
61,553
54,843
50,022
47,686
41,501
37,193
5.3%
LIABILITIES
Current Liabilities
32Accounts payable
1,110
1,348
1,453
1,245
1,062
1,346
1,056
1,158
1,381
1,355
1,294
1.6%
33Short-term debt
1,000
269.7
1,796
657.1
1,534
3,502
3,440
1,331
2,018
87.7
2,043
7.4%
34Other current liabilities
2,013
3,423
3,137
2,686
2,973
5,715
5,388
4,257
4,378
4,336
3,758
6.4%
35Total Current Liabilities
4,122
5,041
6,385
4,588
5,569
10,563
9,884
6,746
7,777
5,779
7,094
5.6%
Non-Current Liabilities
36Long-term debt
6,296
15,203
12,865
13,161
11,390
22,659
19,918
18,197
16,354
14,218
12,659
7.2%
37Other non-current liabilities
2,084
3,365
3,248
2,819
2,413
5,377
4,548
4,007
3,087
2,868
2,729
2.7%
38Total Non-Current Liabilities
8,380
18,568
16,113
15,980
13,803
28,036
24,466
22,204
19,441
17,086
15,388
6.3%
39Total Liabilities
12,502
23,609
22,499
20,568
19,372
38,599
34,350
28,950
27,218
22,865
22,482
6%
SHAREHOLDERS` EQUITY
40Common stock
5.5
6
6
6
6.1
12.1
12.1
12.1
12.2
12.3
12.5
8.6%
41Retained earnings / (deficit)
4,462
4,942
5,645
6,011
6,031
5,361
3,689
5,176
4,640
3,419
(388.3)
-
42Accumulated other comprehensive income / (loss)
(1,764)
(2,264)
(361.2)
(1,441)
(1,797)
(858)
(1,744)
(2,761)
(2,747)
(3,213)
(2,707)
4.4%
43Noncontrolling interests
1.4
1.4
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
9,766
11,118
13,308
12,167
11,884
22,954
20,493
21,072
20,467
18,636
14,711
4.2%
45Total Liabilities and shareholders' Equity
22,268
34,726
35,806
32,735
31,256
61,553
54,843
50,022
47,686
41,501
37,193
5.3%
46Total Debt
7,306
15,473
14,661
13,818
12,924
26,161
23,358
19,528
18,371
14,306
14,701
7.2%
47Net Debt
6,070
14,474
14,369
13,430
12,449
25,317
22,657
18,268
17,379
13,571
13,353
8.2%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
847.6
480
696
352.5
16.8
(669.9)
(1,269)
2,079
54.7
(634.2)
(3,515)
-
49Depreciation & amortization
1,100
1,491
1,728
1,889
2,019
2,216
4,507
3,028
2,741
2,709
2,798
9.8%
50Share-based compensation expense
92.8
88.9
74.7
(70.6)
56.8
79.2
111.2
116.4
180.7
146.1
177.7
6.7%
51Changes in working capital and other assets
(32.3)
(12.2)
(434.1)
171.2
(289.2)
(393.6)
(331.7)
(2,224)
(176.3)
82.5
2,855
-
52Net cash flows from operating activities
2,009
2,047
2,065
2,342
1,804
1,232
3,017
2,999
2,800
2,303
2,316
1.4%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(362.9)
(390.4)
(275.9)
(252.1)
(406)
(681.2)
(509.4)
(489.4)
(377)
(326)
(378.8)
0.4%
54Purchases of investments / marketable securities
(62.1)
(30.2)
(96.5)
(63.4)
(25.8)
(104.8)
(30.2)
(30.2)
(26.3)
(26)
(23.9)
(9.1)%
55Proceeds from maturities of marketable securities
33.1
21.5
96.6
85.2
27.1
47
29.8
29.9
26.3
26
23.9
(3.2)%
56Other investing activities
(1,178)
(7,279)
(700.6)
(980.1)
(120.7)
437.9
392
1,964
(387.1)
2,127
(48.9)
(27.3)%
57Net cash flows from investing activities
(1,570)
(7,678)
(976.4)
(1,210)
(525.4)
(301.1)
(117.8)
1,474
(764.1)
1,801
(427.7)
(12.2)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(67.5)
(3.7)
(500.2)
(432)
-
0.6
(17.4)
3.3
(246.9)
(247.5)
(497.9)
22.1%
59Dividends paid, net
-
-
-
-
-
-
(399)
(581.6)
(575.6)
(574.8)
(561.2)
8.9%
60Debt issuance (repayments), net
696.7
5,497
(1,360)
(631.7)
(1,103)
(401.3)
(2,099)
(3,280)
(1,250)
(3,714)
0.1
(58.7)%
61Other financing activities
(24.4)
(148.4)
(33.4)
(27.2)
(66.1)
(205)
(496.5)
(19.5)
(229.8)
205.6
(234.9)
25.4%
62Net cash flows from financing activities
604.8
5,345
(1,893)
(1,091)
(1,169)
(605.7)
(3,012)
(3,878)
(2,302)
(4,330)
(1,294)
-
63Increase (decrease) in cash and cash equivalents
1,011
(89)
(777.1)
19.4
101.8
358.9
(143.8)
556.3
(268.9)
(257.5)
611.9
(4.9)%
64Cash and equivalents, ending balance
1,236
1,147
369.9
389.3
491.1
850
706.2
1,263
993.6
736.1
1,348
0.9%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,646
1,657
1,789
2,090
1,398
550.6
2,508
2,510
2,423
1,977
1,937
1.6%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019

Viatris (VTRS) financial statements and performance

Explore Viatris (VTRS) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.